The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Malaria Rapid Diagnostic Tests (RDTs)-Global Market Insights and Sales Trends 2025
Synopsis
Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services.
The global Malaria Rapid Diagnostic Tests (RDTs) market size is expected to reach US$ 1082.5 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Malaria Rapid Diagnostic Tests (RDTs) in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Malaria Rapid Diagnostic Tests (RDTs) market. Detect Only One Species, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Detect Multiple Species segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Malaria Rapid Diagnostic Tests (RDTs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Malaria Rapid Diagnostic Tests (RDTs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Malaria Rapid Diagnostic Tests (RDTs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Malaria Rapid Diagnostic Tests (RDTs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Malaria Rapid Diagnostic Tests (RDTs) covered in this report include Abbott Laboratories, Alere Inc, Access Bio Inc, Premier Medical Corporation, Alere Inc, Adaltis, BioMérieux, Bio-Rad Laboratories, Inc. and Premier Medical Corporation Pvt. Ltd, etc.
The global Malaria Rapid Diagnostic Tests (RDTs) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Alere Inc
Access Bio Inc
Premier Medical Corporation
Alere Inc
Adaltis
BioMérieux
Bio-Rad Laboratories, Inc.
Premier Medical Corporation Pvt. Ltd
Sysmex Partec GmbH
Global Malaria Rapid Diagnostic Tests (RDTs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Malaria Rapid Diagnostic Tests (RDTs) market, Segment by Type:
Detect Only One Species
Detect Multiple Species
Global Malaria Rapid Diagnostic Tests (RDTs) market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Malaria Rapid Diagnostic Tests (RDTs) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services.
The global Malaria Rapid Diagnostic Tests (RDTs) market size is expected to reach US$ 1082.5 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Malaria Rapid Diagnostic Tests (RDTs) in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Malaria Rapid Diagnostic Tests (RDTs) market. Detect Only One Species, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Detect Multiple Species segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Malaria Rapid Diagnostic Tests (RDTs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Malaria Rapid Diagnostic Tests (RDTs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Malaria Rapid Diagnostic Tests (RDTs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Malaria Rapid Diagnostic Tests (RDTs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Malaria Rapid Diagnostic Tests (RDTs) covered in this report include Abbott Laboratories, Alere Inc, Access Bio Inc, Premier Medical Corporation, Alere Inc, Adaltis, BioMérieux, Bio-Rad Laboratories, Inc. and Premier Medical Corporation Pvt. Ltd, etc.
The global Malaria Rapid Diagnostic Tests (RDTs) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Alere Inc
Access Bio Inc
Premier Medical Corporation
Alere Inc
Adaltis
BioMérieux
Bio-Rad Laboratories, Inc.
Premier Medical Corporation Pvt. Ltd
Sysmex Partec GmbH
Global Malaria Rapid Diagnostic Tests (RDTs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Malaria Rapid Diagnostic Tests (RDTs) market, Segment by Type:
Detect Only One Species
Detect Multiple Species
Global Malaria Rapid Diagnostic Tests (RDTs) market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Malaria Rapid Diagnostic Tests (RDTs) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Malaria Rapid Diagnostic Tests (RDTs)
1.1 Malaria Rapid Diagnostic Tests (RDTs) Market Overview
1.1.1 Malaria Rapid Diagnostic Tests (RDTs) Product Scope
1.1.2 Malaria Rapid Diagnostic Tests (RDTs) Market Status and Outlook
1.2 Global Malaria Rapid Diagnostic Tests (RDTs) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Malaria Rapid Diagnostic Tests (RDTs) Market Size by Region (2018-2029)
1.4 Global Malaria Rapid Diagnostic Tests (RDTs) Historic Market Size by Region (2018-2023)
1.5 Global Malaria Rapid Diagnostic Tests (RDTs) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Malaria Rapid Diagnostic Tests (RDTs) Market Size (2018-2029)
1.6.1 North America Malaria Rapid Diagnostic Tests (RDTs) Market Size (2018-2029)
1.6.2 Europe Malaria Rapid Diagnostic Tests (RDTs) Market Size (2018-2029)
1.6.3 Asia-Pacific Malaria Rapid Diagnostic Tests (RDTs) Market Size (2018-2029)
1.6.4 Latin America Malaria Rapid Diagnostic Tests (RDTs) Market Size (2018-2029)
1.6.5 Middle East & Africa Malaria Rapid Diagnostic Tests (RDTs) Market Size (2018-2029)
2 Malaria Rapid Diagnostic Tests (RDTs) Market by Type
2.1 Introduction
2.1.1 Detect Only One Species
2.1.2 Detect Multiple Species
2.2 Global Malaria Rapid Diagnostic Tests (RDTs) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Malaria Rapid Diagnostic Tests (RDTs) Historic Market Size by Type (2018-2023)
2.2.2 Global Malaria Rapid Diagnostic Tests (RDTs) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Type (2018-2029)
3 Malaria Rapid Diagnostic Tests (RDTs) Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Malaria Rapid Diagnostic Tests (RDTs) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Malaria Rapid Diagnostic Tests (RDTs) Historic Market Size by Application (2018-2023)
3.2.2 Global Malaria Rapid Diagnostic Tests (RDTs) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Malaria Rapid Diagnostic Tests (RDTs) Revenue Breakdown by Application (2018-2029)
4 Malaria Rapid Diagnostic Tests (RDTs) Competition Analysis by Players
4.1 Global Malaria Rapid Diagnostic Tests (RDTs) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Malaria Rapid Diagnostic Tests (RDTs) as of 2022)
4.3 Date of Key Players Enter into Malaria Rapid Diagnostic Tests (RDTs) Market
4.4 Global Top Players Malaria Rapid Diagnostic Tests (RDTs) Headquarters and Area Served
4.5 Key Players Malaria Rapid Diagnostic Tests (RDTs) Product Solution and Service
4.6 Competitive Status
4.6.1 Malaria Rapid Diagnostic Tests (RDTs) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.1.4 Abbott Laboratories Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Alere Inc
5.2.1 Alere Inc Profile
5.2.2 Alere Inc Main Business
5.2.3 Alere Inc Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.2.4 Alere Inc Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.2.5 Alere Inc Recent Developments
5.3 Access Bio Inc
5.3.1 Access Bio Inc Profile
5.3.2 Access Bio Inc Main Business
5.3.3 Access Bio Inc Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.3.4 Access Bio Inc Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.3.5 Premier Medical Corporation Recent Developments
5.4 Premier Medical Corporation
5.4.1 Premier Medical Corporation Profile
5.4.2 Premier Medical Corporation Main Business
5.4.3 Premier Medical Corporation Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.4.4 Premier Medical Corporation Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.4.5 Premier Medical Corporation Recent Developments
5.5 Alere Inc
5.5.1 Alere Inc Profile
5.5.2 Alere Inc Main Business
5.5.3 Alere Inc Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.5.4 Alere Inc Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.5.5 Alere Inc Recent Developments
5.6 Adaltis
5.6.1 Adaltis Profile
5.6.2 Adaltis Main Business
5.6.3 Adaltis Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.6.4 Adaltis Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.6.5 Adaltis Recent Developments
5.7 BioMérieux
5.7.1 BioMérieux Profile
5.7.2 BioMérieux Main Business
5.7.3 BioMérieux Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.7.4 BioMérieux Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.7.5 BioMérieux Recent Developments
5.8 Bio-Rad Laboratories, Inc.
5.8.1 Bio-Rad Laboratories, Inc. Profile
5.8.2 Bio-Rad Laboratories, Inc. Main Business
5.8.3 Bio-Rad Laboratories, Inc. Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.8.4 Bio-Rad Laboratories, Inc. Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Laboratories, Inc. Recent Developments
5.9 Premier Medical Corporation Pvt. Ltd
5.9.1 Premier Medical Corporation Pvt. Ltd Profile
5.9.2 Premier Medical Corporation Pvt. Ltd Main Business
5.9.3 Premier Medical Corporation Pvt. Ltd Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.9.4 Premier Medical Corporation Pvt. Ltd Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.9.5 Premier Medical Corporation Pvt. Ltd Recent Developments
5.10 Sysmex Partec GmbH
5.10.1 Sysmex Partec GmbH Profile
5.10.2 Sysmex Partec GmbH Main Business
5.10.3 Sysmex Partec GmbH Malaria Rapid Diagnostic Tests (RDTs) Products, Services and Solutions
5.10.4 Sysmex Partec GmbH Malaria Rapid Diagnostic Tests (RDTs) Revenue (US$ Million) & (2018-2023)
5.10.5 Sysmex Partec GmbH Recent Developments
6 North America
6.1 North America Malaria Rapid Diagnostic Tests (RDTs) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Malaria Rapid Diagnostic Tests (RDTs) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Malaria Rapid Diagnostic Tests (RDTs) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Malaria Rapid Diagnostic Tests (RDTs) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Malaria Rapid Diagnostic Tests (RDTs) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Malaria Rapid Diagnostic Tests (RDTs) Market Dynamics
11.1 Malaria Rapid Diagnostic Tests (RDTs) Industry Trends
11.2 Malaria Rapid Diagnostic Tests (RDTs) Market Drivers
11.3 Malaria Rapid Diagnostic Tests (RDTs) Market Challenges
11.4 Malaria Rapid Diagnostic Tests (RDTs) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
